Fulgent Therapeutics
Temple City, US · Founded 2012 · California LLC
Founders & leadership
Fulgent Therapeutics was founded in 2012 by Ming Hsieh.
MH
Ming HsiehManager
Reported raises · per SEC filings
Form D private placements$29.4M disclosed across 2 rounds · 2015–2016
▶$27.2MraisedMay 2016 · 1 investors · BiotechnologyRule 506(b)
▶$27.2MraisedMay 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ming HsiehExecutive Officer, Director
- Offering amount
- $27.2M
- Amount sold
- $27.2M
- First sale
- May 2016
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
▶$2.3MraisedOct 2015 · 4 investors · BiotechnologyRule 506(b)
▶$2.3MraisedOct 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ming HsiehExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $2.3M
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Fulgent Therapeutics?
- Fulgent Therapeutics was founded by Ming Hsieh in 2012.
- How much funding has Fulgent Therapeutics raised?
- Fulgent Therapeutics has disclosed $29.4M raised across 2 rounds.
- Where is Fulgent Therapeutics headquartered?
- Fulgent Therapeutics is headquartered in Temple City, US.